Toyonaka, Japan

Daisuke Taniyama

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Shionogi Company Limited. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daisuke Taniyama. Retrieved from https://idiyas.com/inventor/daisuke-taniyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Daisuke Taniyama: Innovator in Pharmaceutical Research

Introduction

Daisuke Taniyama is a notable inventor based in Toyonaka, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds with therapeutic effects.

Latest Patents

Taniyama holds 2 patents that focus on innovative compounds. His latest patents include "Tricyclic heterocycle derivatives having HIV replication inhibitory effect," which presents a compound with anti-HIV activity. Another patent is for a "Heterocyclic derivative having PGD2 receptor antagonist activity," related to a compound represented by a specific formula.

Career Highlights

Daisuke Taniyama is associated with Shionogi Company Limited, a prominent pharmaceutical company. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

He has collaborated with notable coworkers, including Takashi Kawasuji and Shuichi Sugiyama, enhancing the research and development efforts within his team.

Conclusion

Daisuke Taniyama's innovative work in pharmaceutical research exemplifies the impact of dedicated inventors in the fight against diseases. His contributions continue to pave the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…